Gestational Diabetes Mellitus in Pregnant Women with Systemic Lupus Erythematosus Sofia Gernaat, PhD – Department of Medicine, Solna, Clinical Epidemiology Division, Karolinska Institutet
9:00 AM – 11:00 AM ET
Trajectory of Damage Accrual in African-American vs. Caucasian Systemic Lupus Erythematosus Romy Kallas, MD – Lankenau Medical Center
9:00 AM – 11:00 AM ET
The Impact of Antimalarial Agents on Traditional and Non-traditional Cardiovascular Markers in Patients with Systemic Lupus Erythematosus: A Systematic Review and Meta-analysis Claudia Mendoza-Pinto, MD – Instituto Mexicano del Seguro Social
9:00 AM – 11:00 AM ET
Longitudinal Relationships Between Depression, Anxiety and Cognition in Lupus Kathleen Bingham, MD, PhD – University Health Network
9:00 AM – 11:00 AM ET
Antiphospholipid Patterns Predict the Risk of Thrombosis in Systemic Lupus Erythematosus Michelle Petri, MD, MPH – Johns Hopkins University School of Medicine
9:00 AM – 11:00 AM ET
Single LAC Positivity versus Double and Triple Positivity for Thrombosis in SLE Michelle Petri, MD, MPH – Johns Hopkins University School of Medicine
9:00 AM – 11:00 AM ET
Association of the Systemic Lupus International Collaborating Clinics Frailty Index (SLICC-FI) and Damage Accrual in Long Standing Systemic Lupus Erythematosus Kaitlin Lima, MD – Northwestern University
9:00 AM – 11:00 AM ET
Mortality in Patients with Systemic Lupus Erythematosus and Neuropsychiatric Symptoms Rory Monahan, PhD – Leiden University Medical Center
9:00 AM – 11:00 AM ET
2019 Lupus Classification Criteria Score Predicting Cost of Future Hospitalizations Saurav Suman, MD – University of Kentucky
9:00 AM – 11:00 AM ET
Multivariate Risk Model Shows Different Risk Factors for Myocardial Infarction and Stroke in SLE Michelle Petri, MD, MPH – Johns Hopkins University School of Medicine
9:00 AM – 11:00 AM ET
Perceived Stress During the COVID-19 Pandemic Independently Associates with Worse Patient-Reported Outcomes in Systemic Lupus Erythematosus (SLE) Sarah Patterson, MD – University of California, San Francisco
9:00 AM – 11:00 AM ET
Structural Validity of a Comprehensive Neuropsychological Battery for Assessment of Cognitive Impairment in Systemic Lupus Erythematosus: Exploratory Factor Analysis Confirms Six Cognitive Domains Bahar Moghaddam, MD – Icahn School of Medicine, Mount Sinai
9:00 AM – 11:00 AM ET
Evaluation of a Patient-reported Frailty Tool in Women with Systemic Lupus Erythematosus Sarah B. Lieber, MD, MS – Hospital for Special Surgery
9:00 AM – 11:00 AM ET
Trend of Survival of a Cohort of Patients with Systemic Lupus Erythematosus over 25 Years Chi Chiu Mok, MD – Tuen Mun Hospital
9:00 AM – 11:00 AM ET
Post-Traumatic Stress Disorder (PTSD) and Risk of Systemic Lupus Erythematosus (SLE) Among Medicaid Recipients Siobhan Case, MD, BA, MHS – Brigham and Women's Hospital
9:00 AM – 11:00 AM ET
Impact of Remission and Low Disease Activity Status on Hospitalizations Among SLE Patients from the GLADEL Latin American Cohort Guillermo J. Pons-Estel, MD, PhD – Centro Regional de Enfermedades Autoinmunes y Reumaticas (CREAR)
9:00 AM – 11:00 AM ET
The Impact of the COVID-19 Pandemic on the Fibromyalgia Symptoms of SLE Patients Rebecca E. Sadun, MD, PhD – Duke University
9:00 AM – 11:00 AM ET
COVID-19 in Patients with Systemic Lupus Erythematosus Ruth Fernandez Ruiz, MD – NYU Langone
9:00 AM – 11:00 AM ET
Unexpected Changes in Physical and Psychological Measures Among Georgia Lupus Patients During the Early Weeks of the COVID-19 Pandemic in the United States, March 30–April 21, 2020 S. Sam Lim, MD, MPH – Emory University
9:00 AM – 11:00 AM ET
Using Classification and Regression Tree Analysis to Assess the Construct Validity of the Automated Neuropsychological Assessment Metrics in the Assessment of Cognitive Impairment in SLE Compared to the ACR Neuropsychological Battery Kimberley Yuen, BSc – Queen's University School of Medicine
9:00 AM – 11:00 AM ET
Low Cost Composite Markers to Differentiate Infection from Disease Activity in a Febrile Patient with Systemic Lupus Erythematosus Pankti Mehta, MD – Sanjay Gandhi Postgraduate Institiue of Medical Sciences
9:00 AM – 11:00 AM ET
Does Co-existing Systemic Lupus Erythematosus Affect Outcomes of Hospitalizations for Ischemic Stroke? Ehizogie Edigin – John H Stroger Jr. Hospital of Cook County
9:00 AM – 11:00 AM ET
Clinical Characteristics and Impact of the COVID-19 Pandemic in Systemic Lupus Erythematosus Patients in a Spanish Tertiary Hospital Andrea Briones Figueroa, MD – Hospital Universitario Ramón y Cajal
9:00 AM – 11:00 AM ET
COVID-19 Infections May Increase the Risk of SLE Flares Leila Khalili, FNP – Columbia University Medical Center
9:00 AM – 11:00 AM ET
Opioid-Related Encounters as a Predictor of 30-Day Readmissions in Lupus Christie M. Bartels, MD, MS – University of Wisconsin School of Medicine and Public Health
9:00 AM – 11:00 AM ET
The Impact of High Disease Activity as Measured by SLEDAI and Drug Burden on Healthcare Utilization, Quality of Life and Work Productivity in Systemic Lupus Erythematosus Patients Zahi Touma, MD, PhD – University of Toronto
9:00 AM – 11:00 AM ET
Factors Affecting Mortality of Systemic Lupus Erythematosus Patients in Spain in the 21st Century: Data from the RELESSER Registry Clara Moriano Morales, MD – Hospital León
9:00 AM – 11:00 AM ET
Application of a Novel Method for Determination of Muscle Mass Relative to Fat Mass in Women with Systemic Lupus Erythematosus and Association with Disability Sarah B. Lieber, MD, MS – Hospital for Special Surgery
9:00 AM – 11:00 AM ET
Association of Frailty with Disability Is Not Attenuated by Lean Body Mass in Women with SLE Sarah B. Lieber, MD, MS – Hospital for Special Surgery
9:00 AM – 11:00 AM ET
Personalizing Cardiovascular Risk Prediction for Patients with Systemic Lupus Erythematosus by Physician Global Assessment of Disease Activity May Choi, MD, FRCPC – Brigham and Women's Hospital | University of Calgary
9:00 AM – 11:00 AM ET
Prevalence of Morbidity Prior to Diagnosis of Incident Systemic Lupus Erythematosus in the Danish Population Renata Baronaite Hansen, MD – Copenhagen Lupus and Vasculitis Clinic
9:00 AM – 11:00 AM ET
Predictors of Frailty Identified by the Short Physical Performance Battery and Associations with Patient-reported Outcomes Patricia Katz, PhD – UCSF
9:00 AM – 11:00 AM ET
Sex Differences in Mental Health and Quality of Life and Their Impact in the Treatment of Patients with Systemic Lupus Erythematosus Lilian Guadalupe Cano Cruz, MD – INSTITUTO NACIONAL DE CIENCIAS MEDICAS Y NUTRICION SALVADOR ZUBIRAN
9:00 AM – 11:00 AM ET
A Multitrait-Multimethod Matrix Approach to the Construct Validity of Patient Reported Outcomes Measurement Information System Computerized (PROMIS) Adaptive Tests (CAT) in Systemic Lupus Erythematous Mitra Moazzami, MS – The George Washington University
9:00 AM – 11:00 AM ET
Depressed Symptomatology Persists over Time in the Majority of Systemic Lupus Erythematosus Patients and Is Independent of Disease Activity Sara Kellahan, NP – Washington University
9:00 AM – 11:00 AM ET
Frequency and Predictors of Influenza Vaccine Hesitancy in Systemic Autoimmune Rheumatic Diseases Valeria Valerio, MD – Research Institute of MUHC
9:00 AM – 11:00 AM ET
Factors Associated with Early Hospital Readmission in Systemic Lupus Erythematosus: Data from National Readmission Database Rashmi Dhital, MD – Reading Hospital
9:00 AM – 11:00 AM ET
Prediction of Damage in SLE Using Unbiased Analysis of Large Datasets Eric F. Morand, MD, PhD – Monash University
9:00 AM – 11:00 AM ET
Disease Activity and Mental Health in SLE Patients: A Cross-section Study with Self-Assessments Based on Smart System of Disease Management (SSDM) Mobile Tools Yongfu Wang, MD – Rheumatology
9:00 AM – 11:00 AM ET
Associations of Metabolic Syndrome and Adipokines in SLE Diane Apostolopoulos, MBBS – Monash University
9:00 AM – 11:00 AM ET
Lupus Antibodies in Relation to Malignancy Sarah Huse, DO – Medical University of South Carolina
9:00 AM – 11:00 AM ET
Lupus Damage Free-Survival by Age at Diagnosis: A Retrospective Incident Lupus Cohort Maria Schletzbaum, BA – University of Wisconsin School of Medicine and Public Health
9:00 AM – 11:00 AM ET
Longitudinal Patterns of Anxiety Symptomology Among Patients with Systemic Lupus Erythematosus (SLE) Remain Stable over Time and Do Not Associate with SLE Disease Activity Daphne Lew, PhD, MPH – Washington University in St. Louis School of Medicine
9:00 AM – 11:00 AM ET
Identifying Cognitive Impairment in Patients with Systemic Lupus Erythematosus Using Hidden Markov Models: A Bayesian Approach Juan Pablo Diaz Martinez, PhD – UHN
9:00 AM – 11:00 AM ET
Characterizing How SLE Patients Access Health Information Pre and During COVID-19 Francesca Cardwell, PhD – University of Waterloo
9:00 AM – 11:00 AM ET
Exploration of Machine Learning Methods in Predicting Systemic Lupus Erythematosus Hospitalizations April Jorge, MD – Massachusetts General Hospital
